|
Forecast Period
|
2024-2028
|
|
Market Size (2022)
|
USD 0.93 Billion
|
|
CAGR (2023-2028)
|
10.19%
|
|
Fastest Growing Segment
|
Disease Diagnosis
|
|
Largest Market
|
North America
|
Market Overview
Global Digital Pathology Market has
valued at USD 0.93 billion in 2022 and is anticipated to project impressive
growth in the forecast period with a CAGR of 10.19% through 2028. Digital
pathology is a specialized field that focuses on extracting data from digitized
specimen slides. By utilizing computer-based technology and virtual microscopy,
digital pathology enables the acquisition of image-based information. This
innovative approach has significantly enhanced the efficiency, workflow, and
revenue of pathology labs worldwide. Through the conversion of glass slides into
digital counterparts, users can effortlessly manage, share, view, and analyze
them on a computer monitor. Digital pathology finds applications in various
areas, including primary disease diagnosis, diagnostic decision support,
intraoperative diagnosis, diagnostic consultation, resident and medical
training, peer review, manual and semi-quantitative immunohistochemistry (IHC)
review, and clinical research. Its implementation has led to improved
laboratory efficiency and faster diagnostic results. With growing support from
the education sector, drug development, tissue-based research, and disease
diagnosis, digital pathology is rapidly gaining recognition as an essential and
proven technology in the healthcare sector.
Key Market Drivers
Enhanced
Lab Efficiency
Digital pathology enhances efficiency by
reducing turnaround time, lowering costs, and delivering comprehensive details
to users with subject-matter expertise. Enhancing laboratory results is crucial
as physicians and patients rely heavily on them for disease diagnosis and
treatment. Digital pathology allows for rapid and remote access to pathology
images, enabling faster collaboration among healthcare professionals.
Pathologists and experts can review cases and provide consultations without the
constraints of physical distance, potentially leading to quicker diagnosis and
treatment decisions. Traditional pathology involves preparing and transporting
physical slides, which can be time-consuming and costly. With digital
pathology, there is a reduction in expenses related to slide production,
shipping, storage, and retrieval. The increasing demand for accurate,
efficient, and prompt laboratory results is fueling the growth of the digital
pathology market.
Rapid Technological
Advancements
Rapid advancements in digital pathology
systems are anticipated to fuel market growth. Digital imaging,
computerization, robotic light microscopy, and fiber optic communications all
play a significant role in this expansion. Whole slide imaging, a technique
with numerous advantages over conventional light microscopes, is projected to
positively impact the market. Moreover, the development of microarrays and a
wide range of predictive models, such as hybrid models and API algorithms, is
anticipated to further accelerate market growth for digital image analysis. The
increasing preference for computer-aided diagnosis, which integrates image
processing, physics, mathematics, and computational algorithms, facilitates
efficient disease detection and enables the assessment of anatomical structures
of interest, disease progression, and risk assessment.
Rising
Use of AI In Healthcare
The utilization of AI in healthcare is
on the rise, with a growing focus on enhancing patient care quality through the
integration of AI in different healthcare services, including pathological
diagnosis. AI algorithms can analyze large volumes of pathology images quickly
and accurately. They can assist pathologists in detecting abnormalities,
identifying patterns, and providing more precise diagnoses, ultimately leading
to faster treatment decisions and improved patient outcomes. AI can help
mitigate human errors and variability in pathological diagnosis by providing
objective and consistent analyses. This is especially valuable for complex
cases where subtle features might be missed. By integrating patient data with
AI insights, pathologists and clinicians can tailor treatment plans to
individual patients, optimizing therapeutic approaches and minimizing
unnecessary interventions. Consequently, artificial intelligence (AI)
facilitates streamlined primary care processes and automation, enabling
physicians to prioritize patients with more critical conditions. Additionally,
AI solutions in the healthcare industry are progressively adopting a more
human-centered approach.
Increasing
Prevalence of Cancer
According to the World Health
Organization, there were an unprecedented 9.6 million deaths and 18.1 million
new cancer cases recorded worldwide in 2018. The increasing aging population
and sedentary lifestyles globally are contributing to the rising number of
cancer cases. The UN organization predicts that the number of older persons
will reach nearly 2.1 billion by 2050. Preclinical research using animal models
and clinical trials play a vital role in determining the safety and efficacy of
drugs. Digital pathology offers multiple benefits such as reducing the risk of
error, storing drug data, integrating data into electronic health records
(EHRS), and assessing patient reactions to specific medications. The global
digital pathology industry is experiencing growth due to the increasing focus
on drug development and drug discovery research and development, leading to a
rise in clinical and preclinical trials. The demand for faster diagnostic tools
for chronic diseases like cancer and the need to enhance workflow productivity
are driving factors. Additionally, the growing geriatric population, which is
more susceptible to chronic conditions, is expected to further increase the
demand for advanced technical diagnostic procedures.
Download Free Sample Report
Key Market Challenges
High
Cost of Digital Pathology
The high cost of digital pathology and
the low adoption rate in emerging and underdeveloped countries present
obstacles to the market's growth. Augmenting addresses this challenge by
offering a modular hardware platform with integrated digital pathology software
applications, helping to keep costs low. Implementing digital pathology systems
requires significant upfront investment in scanners, storage infrastructure,
and software solutions. The expenses associated with digitizing slides,
maintaining digital archives, and training personnel can be substantial,
especially for small laboratories or healthcare facilities with limited
budgets. Furthermore, integrating digital pathology into existing laboratory
workflows and the need for IT support and infrastructure upgrades can pose
challenges for some organizations.
Regulatory
and Standardization Challenges
The adoption of digital pathology is influenced
by regulatory requirements and standards that vary across different regions.
The validation and regulatory approval of digital pathology systems and
software can be a complex and time-consuming process. Additionally, addressing
challenges related to data privacy, security, and compliance with patient
confidentiality regulations during the transmission and storage of digital
pathology images is crucial. Before digital pathology solutions can be used for
clinical diagnosis, they often need to undergo rigorous validation processes to
demonstrate their accuracy, reliability, and safety. Regulatory authorities in
different regions may have varying criteria for approving these technologies.
Patient data security and privacy are paramount in healthcare. Digital
pathology systems must adhere to strict data protection regulations, such as
the Health Insurance Portability and Accountability Act (HIPAA) in the United
States and the General Data Protection Regulation (GDPR) in the European Union.
Key Market Trends
Telepathology
and Remote Consultation
The increasing adoption of telepathology
enables remote diagnosis and consultation, allowing pathologists to collaborate
and provide expert opinions without being limited by geographical constraints.
Telepathology has gained significant prominence during the COVID-19 pandemic,
as it facilitates remote working and minimizes the risk of exposure for
pathologists. For instance, pathologists can remotely review and discuss cases
with colleagues, participate in multidisciplinary tumor boards, or offer consultations
to underserved areas or regions facing a shortage of pathology expertise. The
increasing preference for computer-aided diagnosis, integrating image
processing, physics, mathematics, and computing algorithms, facilitates
efficient disease detection. It also assists in evaluating anatomic structures
of interest, quantifying disease progression and risk assessment, thereby
stimulating market growth. Notably, companies like Olympus offer a range of
tools for remote slide sharing and image processing, contributing to
anticipated market expansion in the upcoming years. In April 2020, Leica
Biosystems obtained FDA approval for the Aperio AT2 DX Scanner and Aperio
WebViewer, enabling remote diagnosis during the pandemic. Additionally, during
this emergency, Phillips also received FDA approval for its IntelliSite
Pathology Solution, further supporting remote diagnosis.
Analytics
Integration of Artificial Intelligence and Machine Learning
The incorporation of Artificial
Intelligence (AI) and machine learning algorithms into digital pathology
platforms is a significant and emerging trend. AI has the capability to assist
pathologists in various tasks, including automated tissue recognition, anomaly
detection, biomarker quantification, and disease outcome prediction. These
technologies hold great potential in enhancing efficiency, accuracy, and
reproducibility in pathology diagnosis. For example, AI algorithms can aid in
the automated detection and classification of cancer cells, as well as the
identification of specific features in histopathological images.
Segmental Insights
Application Insights
The disease diagnostic segment is
anticipated to witness significant growth during the forecast period due to the
increasing prevalence of chronic diseases. Digital pathology encompasses a
range of technologies for disease diagnosis, including laboratory management
systems, digital dictation, dashboards and workflow control, digital image
analysis, electronic specimen labeling and monitoring, and synoptic reporting
tools. Manufacturers are currently focused on the development of novel and
rapid diagnostic techniques. The integration of digital technology enhances
every phase of the diagnostic process and facilitates seamless information
exchange within and between departments.
End User Insights
The of pharmaceutical and biotechnology
companies represents the largest portion of global digital pathology demand by
end-users. The significant share and rapid growth rate of this segment can be
attributed to various factors. These include the increasing utilization of
digital pathology in drug discovery studies and drug toxicology research.
Additionally, biotechnology corporations leverage digital pathology for the
development of biobanking, biopharmaceutical trials, molecular assays, and
personalized medicine.